We’re thrilled to welcome Aude Thiriot, with 20+ years of expertise in immunology, vascular biology, and oncology, to Compass Therapeutics as Senior Scientist, Discovery Research. #CMPX #biotech #biotechnology #healthcare
Compass Therapeutics Inc.
Biotechnology Research
Boston, MA 7,716 followers
We are developing next-generation antibodies into transformative cancer therapies that improve patients’ lives.
About us
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’ scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. To learn more, visit www.compasstherapeutics.com
- Website
-
http://www.compasstherapeutics.com
External link for Compass Therapeutics Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Boston, MA
- Type
- Public Company
- Founded
- 2014
- Specialties
- Drug Discovery and Development, Biologics, Oncology, and Immuno-Oncology
Locations
-
Primary
Get directions
80 Guest Street
Suite 601
Boston, MA 02135, US
Employees at Compass Therapeutics Inc.
Updates
-
Compass Therapeutics has announced the appointment of Barry Shin as Chief Financial Officer. Mr. Shin is a biopharmaceutical leader with over 20 years of experience as a finance and operations executive, investment banker, and corporate advisor. Read the news release at https://ow.ly/TnYT50UoqmU #CMPX #biotech #biotechnology #healthcare
-
-
Thomas Schuetz , MD, PhD, CEO of Compass Therapeutics, recently presented at the Stifel 2024 Healthcare Conference. Watch Now! Don’t miss his insightful session. Register to view on-demand: https://cmpx.info/stifel #CMPX #Biotech #HealthcareInnovation #Biotechnology
-
-
Join Thomas Schuetz, MD, PhD, CEO of Compass Therapeutics, in an engaging "Lunch with LifeSci" webinar! In this investor-friendly session, designed for generalists and non-PhD viewers, Dr. Schuetz provides valuable insights into our therapeutic initiatives and discusses the exciting potential of our bispecific antibody programs. Watch Now: "Lunch with LifeSci featuring Compass Therapeutics" Register here: https://ow.ly/HQ0O50UaWa7 #CMPX #biotech #biotechnology #healthcare #LifeSciWebinars
-
-
We're pleased to announce that Compass Therapeutics' CEO, Thomas Schuetz, MD, PhD, will be presenting at the prestigious Jefferies London Healthcare Conference. Tune in to the live webcast on Thursday, November 21, at 2 p.m. GMT. Secure your spot by registering here: https://lnkd.in/eFRpMTi3. #CMPX #Biotech #Biotechnology #JefferiesHealthcare
-
-
Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update. Read the news release at https://ow.ly/Bz6G50U5hTl #CMPX #biotech #biotechnology #healthcare
-
-
Join us as we share exciting new biomarker data for CTX-471 at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting during our poster presentation, "Pharmacodynamic and Response Biomarkers in the Monotherapy Arm of a Phase 1 Trial of CTX-471, a Novel Anti-CD137 Agonist Antibody," on Friday November 8th. For more details, visit https://ow.ly/xs2I50U39uj. #SITC24 #CMPX #biotech #biotechnology #clinicaltrials #immunotherapy
-
-
🔬 Join Our Team as a Translational Scientist in Clinical-Stage Biotech Are you a highly motivated, hands-on Translational Scientist ready to transform cancer treatment through antibody therapeutics? We’re seeking an experienced professional to lead our biomarker programs using advanced technologies like NGS and spatial transcriptomics. This onsite position in Brighton, MA, reports directly to our VP and Head of Translational Science. Make your science count. Learn more and apply now: cmpx.info/job. #BiotechJobs #BostonBiotech
-
-
Team Compass joined the “Get Your Rear in Gear – Boston 5K Run/Walk” in support of the Colon Cancer Coalition. https://lnkd.in/eHSrkpS . #CMPX #biotech #biotechnology #coloncancer #gyrig
-
-
Watch the replay of our presentation at the 2024 Cantor Global Healthcare Conference. Conducted by Compass CEO Thomas Schuetz, MD, PhD. Register and watch: www.cmpx.info/cantor #CMPX #biotech #biotechnology #healthcare
-